There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Left ventricular hypertrophy (LVH) is common in hypertensive patients, and it increases the risk of myocardial infarction, stroke, and death. Recent evidence indicates it is a modifiable risk factor that is not entirely dependent on blood pressure control. The authors review its pathogenesis, diagnosis, and treatment.

Related collections

Author and article information

Journal

PubMed ID:: 20516249

DOI:: 10.3949/ccjm.77a.09158

ScienceOpen disciplines: Chemistry

Keywords: Cardiovascular Diseases,diagnosis,etiology,therapy,Humans,Hypertrophy, Left Ventricular,complications,drug therapy,prevention & control,Risk Factors

Data availability:

ScienceOpen disciplines: Chemistry

Keywords: Cardiovascular Diseases, diagnosis, etiology, therapy, Humans, Hypertrophy, Left Ventricular, complications, drug therapy, prevention & control, Risk Factors

Left ventricular hypertrophy: an overlooked cardiovascular risk factor.

Read this article at

Abstract

Related collections

EPA CompTox Chemicals Dashboard

Author and article information

Journal

Comments

Comment on this article

Similar content 370

Cited by 18